Furthermore, GSEA revealed several of the GBM associated signaling pathways to be enriched in the low SRY expressing tumors, for example, EGFR, one of the key tumor regulators, aberrant especially in the classical subtype of GBM [44]. Here, EGFR is linked to neoplasm.